Purchases and Sales Made in Q3 2023 in Intellia Therapeutics, Inc. (NTLA)
This table provides information about the institutional ownership of Intellia Therapeutics, Inc. (NTLA) during Q3 2023. The information is specifically focused on institutions that hold shares of Intellia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-11.3K- 0.55% |
$356K - $516K
|
2.05M
$25M
|
|
|
Nov 13, 2023
Q3 2023
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-11.3K- 2.71% |
$359K - $519K
|
407K
$4.98M
|
|
|
Nov 14, 2023
Q3 2023
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-12.5K- 8.77% |
$394K - $571K
|
130K
$1.58M
|
|
|
Nov 14, 2023
Q3 2023
|
Guggenheim Capital LLC
Chicago, IL |
SELL
|
- |
-15K- 17.27% |
$473K - $685K
|
71.7K
$876K
|
|
|
Nov 14, 2023
Q3 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-16.8K- 4.23% |
$530K - $767K
|
379K
$4.63M
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-24.5K- 35.1% |
$774K - $1.12M
|
45.3K
$553K
|
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-24.6K- 8.84% |
$778K - $1.13M
|
254K
$3.1M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-28.3K- 3.43% |
$894K - $1.29M
|
796K
$9.73M
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-38.3K- 5.87% |
$1.21M - $1.75M
|
615K
$7.52M
|
|
|
Nov 14, 2023
Q3 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-39.1K- 78.11% |
$1.24M - $1.79M
|
11K
$134K
|
|
|
Nov 13, 2023
Q3 2023
|
Candriam S.C.A.
|
SELL
|
- |
-40K- 43.82% |
$1.26M - $1.83M
|
51.3K
$627K
|
|
|
Nov 14, 2023
Q3 2023
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-56.7K- 21.64% |
$1.79M - $2.59M
|
205K
$2.51M
|
|
|
Nov 02, 2023
Q3 2023
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-60K- 96.06% |
$1.9M - $2.75M
|
2.46K
$30.1K
|
|
|
Nov 13, 2023
Q3 2023
|
Contrarius Investment Management LTD
St. Helier, Y9 |
SELL
|
- |
-62.2K- 21.15% |
$1.97M - $2.85M
|
232K
$2.83M
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-67.2K- 32.26% |
$2.13M - $3.08M
|
141K
$1.73M
|
|
|
Nov 08, 2023
Q3 2023
|
Van Eck Associates Corp
|
SELL
|
- |
-82.9K- 98.09% |
$2.62M - $3.8M
|
1.62K
$19.7K
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-89.9K- 45.46% |
$2.84M - $4.11M
|
108K
$1.32M
|
|
|
Nov 14, 2023
Q3 2023
|
Casdin Capital, LLC
New York, NY |
SELL
|
- |
-96.9K- 7.6% |
$3.06M - $4.44M
|
1.18M
$14.4M
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-117K- 57.05% |
$3.7M - $5.35M
|
88K
$1.08M
|
|
|
Nov 14, 2023
Q3 2023
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-121K- 24.44% |
$3.81M - $5.52M
|
373K
$4.55M
|
|
|
Nov 14, 2023
Q3 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-176K- 10.2% |
$5.55M - $8.04M
|
1.55M
$18.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-208K- 20.67% |
$6.56M - $9.5M
|
796K
$9.73M
|
|
|
Nov 13, 2023
Q3 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-249K- 12.3% |
$7.86M - $11.4M
|
1.77M
$21.6M
|
|
|
Nov 08, 2023
Q3 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-271K- 28.49% |
$8.58M - $12.4M
|
681K
$8.32M
|
|
|
Nov 14, 2023
Q3 2023
|
Public Employees Retirement Association Of Colorado
Denver, CO |
SELL
|
- |
-629K- 98.47% |
$19.9M - $28.8M
|
9.76K
$119K
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-662KClosed |
$20.9M - $30.3M
|
0
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-800K- 94.12% |
$25.3M - $36.6M
|
50K
$611K
|